The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study of ribociclib in combination with doxorubicin in advanced soft tissue sarcomas (aSTS).
 
Lara E. Davis
Consulting or Advisory Role - Epizyme; Epizyme
 
Emile Latour
No Relationships to Disclose
 
Reid Burch
No Relationships to Disclose
 
Byung Park
No Relationships to Disclose
 
Jessica L. Davis
Honoraria - Axiom Biotechnologies; Celerity Biosciences; Celerity Biosciences; Celerity Biosciences
Consulting or Advisory Role - Bayer; Epizyme; Loxo
 
Christopher W. Ryan
Consulting or Advisory Role - Deciphera; Eisai; Janssen; Pfizer
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline/Novartis (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Pfizer (Inst); TRACON Pharma (Inst); Xynomic Pharma (Inst)